Kolhapur researchers receives 20 years patent for their Breast Cancer drug

▴ Kolhapur researchers receives 20 years patent for their Breast Cancer drug
A new breakthrough for Breast Cancer patients

Researchers at the Shivaji University Kolhapur (SUK) have received a patent for the chemical complex (molecule) drug synthesised in a university lab which showed anti-breast cancer properties.

Assistant Professor Prakash Bansode under the guidance of Gajanan Rashinkar synthesised the drug molecule for over 3 months.

The molecule contains a Ferrocine compound which normally kills normal cells also during chemotherapy apart from destroying normal cells. To overcome the problem researchers coupled the compound with Carbene structure to which they added metallic components such as Gold, Silver and Platinum. 

According to the researchers, the drug was screened at Advanced Cancer Research Centre of Tata Memorial. The patent application which was filed in March 2018 was reviewed and the drug was granted a 20 years product patent.

Tags : #Kolhapur #ShivajiUniversityKolhapur #ShivajiUniversity #Ferrocine #BreastCancerTreatment #TataCancerMemorial #TataAdvanceResearchCentre #PrakashBansode #GajananRashinkar

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

The Value of Risk Communication in Public HealthOctober 08, 2026
What Makes a Reliable Health Screening Programme?October 08, 2026
How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026